[HTML][HTML] Residual OXPHOS is required to drive primary and metastatic lung tumours in an orthotopic breast cancer model

P Herst, G Carson, D Lewthwaite, D Eccles… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Background Fast adaptation of glycolytic and mitochondrial energy pathways to changes in
the tumour microenvironment is a hallmark of cancer. Purely glycolytic ρ 0 tumour cells do …

[HTML][HTML] Regulation of cellular and molecular markers of epithelial-mesenchymal transition by Brazilin in breast cancer cells

L Cayetano-Salazar, JA Hernandez-Moreno… - PeerJ, 2024 - peerj.com
Breast cancer is the most common invasive neoplasm and the leading cause of cancer
death in women worldwide. The main cause of mortality in cancer patients is invasion and …

Clinical impact of epithelial–mesenchymal transition for cancer therapy

N Mukerjee, S Nag, B Bhattacharya… - Clinical and …, 2024 - Wiley Online Library
The epithelial–mesenchymal transition (EMT) represents a pivotal frontier in oncology,
playing a central role in the metastatic cascade of cancer—a leading global health …